General Information
Version
6.2
Revision date
2022-06-15
Product name
Sulindac, United States Pharmacopeia (USP) Reference Standard
CAS No.
38194-50-2
REACH No
A
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H317, H334, H361
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P284 Wear respiratory protection. P301 + P330 + P331 + IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P310 Immediately call a POISON CENTER/ doctor. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Respiratory sensitization (Category 1), H334 Skin sensitization (Category 1), H317 Reproductive toxicity (Category 2), H361 For the full text of the H-Statements mentioned in this Section, see Section 16.
